Potential Biomarkers for Heart Failure Diagnostics and Management

被引：0
作者：
Tokmachev, Roman Evgenyevich [1 ]
Kravchenko, Andrey Yakovlevich [1 ]
Budnevsky, Andrey Valerievich [1 ]
Chernik, Tatiana Alexandrovna [1 ]
Tokmachev, Evgeny Viktorovich [2 ]
Shkatova, Yanina Sergeevna [1 ]
机构：
[1] Voronezh Burdenko State Med Univ, Dept Internal Med, Voronezh, Russia
[2] Voronezh Burdenko State Med Univ, Dept Disaster Med & Life Safety, Voronezh, Russia
来源：
PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES | 2020年 / 14卷 / 04期
关键词：
chronic heart failure; transforming growth factor-B1; cardiotrophin-1; cystatin S; stimulating growth factor expressed by gene 2 (ST2); CYSTATIN-C CONCENTRATION; GROWTH-FACTOR-BETA; NATRIURETIC-PEPTIDE; SOLUBLE ST2; CARDIOTROPHIN-1; INFLAMMATION; ASSOCIATION; FIBROSIS; RECEPTOR; MARKER;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
At the present time there is a progressive increase in the number of patients with chronic heart failure. Modern treatment is able to delay the progression of the pathological process in such patients, but not restore the normal physiology of the cardiovascular system. For these reasons, a need has emerged for a more detailed study of the biochemical and morphological processes leading to the development of chronic heart failure. This review discusses the potential of transforming growth factor-B1, cardiotrophin-1,Cystatin S andstimulating growth factor expressed by gene 2 (ST2) to become additional heart failure markers which will lead to the improvement of diagnostics and treatment of stable and decompensated heart failure.
引用
收藏
页码：1813 / 1816
页数：4
相关论文
共 32 条
[1]   ST2 Pathogenetic Profile in Ambulatory Heart Failure Patients [J].
Bayes-Genis, Antoni ;
Januzzi, James L. ;
Gaggin, Hanna K. ;
de Antonio, Marta ;
Motiwala, Shweta R. ;
Zamora, Elisabet ;
Galan, Amparo ;
Domingo, Mar ;
Urrutia, Agustin ;
Lupon, Josep .
JOURNAL OF CARDIAC FAILURE, 2015, 21 (04) :355-361
[2]   Transforming growth factor beta 1 (TGF-beta 1) in atrial fibrillation and acute congestive heart failure [J].
Behnes, Michael ;
Hoffmann, Ursula ;
Lang, Siegfried ;
Weiss, Christel ;
Ahmad-Nejad, Parviz ;
Neumaier, Michael ;
Borggrefe, Martin ;
Brueckmann, Martina .
CLINICAL RESEARCH IN CARDIOLOGY, 2011, 100 (04) :335-342
[3]   The Multi-Biomarker Approach for Heart Failure in Patients with Hypertension [J].
Bielecka-Dabrowa, Agata ;
Gluba-Brzozka, Anna ;
Michalska-Kasiczak, Marta ;
Misztal, Malgorzata ;
Rysz, Jacek ;
Banach, Maciej .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (05) :10715-10733
[4]   Biomarkers in heart failure [J].
Braunwald, Eugene .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (20) :2148-2159
[5]  
Budnevsky AV, 2017, KARDIOLOGIYA, V57, P89, DOI [10.18565/cardio.2017.4.89-93, .org/10.18565/cardio.2017.4.89-93]
[6]   Cardiotrophin-1 plasma levels are increased in patients with diastolic heart failure [J].
Celik, Atac ;
Sahin, Semsettin ;
Koc, Fatih ;
Karayakli, Metin ;
Sahin, Mehmet ;
Benli, Ismail ;
Kadi, Hasan ;
Burucu, Turgay ;
Ceyhan, Koksal ;
Erkorkmaz, Unal .
MEDICAL SCIENCE MONITOR, 2012, 18 (01) :CR25-CR31
[7]  
Dalzell JR, 2014, BIOMARK MED, V8, P833, DOI [10.2217/bmm.14.51, 10.2217/BMM.14.51]
[8]   Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target [J].
Dobrev, Dobromir .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2010, 381 (03) :195-206
[9]   Cystatin C levels are associated with the prognosis of systolic heart failure patients [J].
Gao, Changlu ;
Zhong, Lihua ;
Gao, Yanhui ;
Li, Xueqi ;
Zhang, Mingyu ;
Wei, Shipeng .
ARCHIVES OF CARDIOVASCULAR DISEASES, 2011, 104 (11) :565-571
[10]   Cystatin C as a marker of glomerular filtration rate: prospects and limitations [J].
Inker, Lesley A. ;
Okparavero, Aghogho .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2011, 20 (06) :631-639
1234